Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Di Mambro

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Biological Macromolecules|May 7, 2026
Predicting the success of an antibody: Biochemical and biophysical characterization of the humanized monoclonal antibody Dia-T51Tania Vanzolini, Valentina Fiori, Tomas Di Mambro, et al.
RSC Advances|February 23, 2023
AFM evaluation of a humanized recombinant antibody affecting <i>C. auris</i> cell wall and stabilityTania Vanzolini, Tomas Di Mambro, Mauro Magnani, et al.
Frontiers in Pharmacology|February 27, 2019
The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?Tomas Di Mambro, Ilaria Guerriero, Luigi Aurisicchio, et al.
Scientific Reports|October 6, 2018
Humanization of Antibodies using a Statistical Inference ApproachAlejandro Clavero-Álvarez, Tomas Di Mambro, Sergio Perez-Gaviro, et al.
Plos One|October 31, 2022
Development and in vitro characterization of a humanized scFv against fungal infectionsTomas Di Mambro, Tania Vanzolini, Marzia Bianchi, et al.
International Journal of Molecular Sciences|April 3, 2021
Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral InfectionAlessandra Fraternale, Carolina Zara, Marta De Angelis, et al.
Plos One|February 12, 2024
Development and characterization of DIA 12.3, a fully human intact anti-CEACAM1 monoclonal antibodyMichela Centonze, Valentina Fiori, Maciej Kujawski, et al.
Scientific Reports|October 1, 2021
A new humanized antibody is effective against pathogenic fungi in vitroTomas Di Mambro, Tania Vanzolini, Pierpaolo Bruscolini, et al.
Biotechnology Journal|October 6, 2023
A biotechnological approach for the production of new protein bioplasticsFrancesca De Marchis, Tania Vanzolini, Elisa Maricchiolo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 18, 2020
I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein responseAlessandra Fraternale, Carolina Zara, Tomas Di Mambro, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Biological Macromolecules|May 7, 2026
Predicting the success of an antibody: Biochemical and biophysical characterization of the humanized monoclonal antibody Dia-T51Tania Vanzolini, Valentina Fiori, Tomas Di Mambro, et al.
RSC Advances|February 23, 2023
AFM evaluation of a humanized recombinant antibody affecting <i>C. auris</i> cell wall and stabilityTania Vanzolini, Tomas Di Mambro, Mauro Magnani, et al.
Frontiers in Pharmacology|February 27, 2019
The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?Tomas Di Mambro, Ilaria Guerriero, Luigi Aurisicchio, et al.
Scientific Reports|October 6, 2018
Humanization of Antibodies using a Statistical Inference ApproachAlejandro Clavero-Álvarez, Tomas Di Mambro, Sergio Perez-Gaviro, et al.
Plos One|October 31, 2022
Development and in vitro characterization of a humanized scFv against fungal infectionsTomas Di Mambro, Tania Vanzolini, Marzia Bianchi, et al.
International Journal of Molecular Sciences|April 3, 2021
Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral InfectionAlessandra Fraternale, Carolina Zara, Marta De Angelis, et al.
Plos One|February 12, 2024
Development and characterization of DIA 12.3, a fully human intact anti-CEACAM1 monoclonal antibodyMichela Centonze, Valentina Fiori, Maciej Kujawski, et al.
Scientific Reports|October 1, 2021
A new humanized antibody is effective against pathogenic fungi in vitroTomas Di Mambro, Tania Vanzolini, Pierpaolo Bruscolini, et al.
Biotechnology Journal|October 6, 2023
A biotechnological approach for the production of new protein bioplasticsFrancesca De Marchis, Tania Vanzolini, Elisa Maricchiolo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 18, 2020
I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein responseAlessandra Fraternale, Carolina Zara, Tomas Di Mambro, et al.
Pageof 2